Female Pelvic Medicine and Neurourology News and Latest Research
- Phase 3 trial registered testing berobenatide for stress incontinence in women with obesity Trial registered · ClinicalTrials.gov · 2026-11-12
A planned 900-participant, roughly 63-week trial will evaluate the safety and effectiveness of berobenatide in women with stress urinary incontinence who also have obesity or overweight. Registered on ClinicalTrials.gov and not yet recruiting; estimated start 2026-11-17; planned enrollment 900.
Why it matters: A positive trial could add a pharmacologic option for SUI in a population where weight is a known risk factor and surgical candidacy may be limited.
- Large EHR study finds no higher dementia risk with anticholinergics vs beta-3 agonists for OAB Retrospective · JAMA Netw Open · 2026-11-07
Among 830,393 adults newly treated for overactive bladder using Epic Cosmos data, high-risk anticholinergics were associated with a lower hazard of incident dementia than beta-3 agonists (HR 0.90) or low-risk anticholinergics (HR 0.93).
Why it matters: Raises the question about the presumed cognitive safety advantage of beta-3 agonists over anticholinergics for OAB, but is hypothesis generating from registry data lacking randomization and potential confounding by…
- Urinary incontinence changes linked to falls, functional decline, and depression across global aging cohorts Prospective · Int Urogynecol J · 2026-11-07
In a harmonized analysis of 85,788 older adults from five international cohorts, incident, remitting, and persistent urinary incontinence were each associated with higher odds of falls, ADL decline, and depressive symptoms compared with no incontinence.
Why it matters: Adds support for monitoring functional and mental health trajectories in older adults with any history of urinary incontinence, including those whose symptoms resolve.
- Systematic review compares obliterative vs reconstructive surgery for advanced prolapse in older women Review · Int Urogynecol J · 2026-11-07
A systematic review of 27 study families (29 reports) narratively synthesized comparative data, since heterogeneity precluded pooling. Obliterative surgery was linked to shorter operative time (12/14 comparisons) and lower recurrence-related reoperation (7/8), but overall complications were not consistently lower, and certainty of evidence was low to very low across outcomes.
Why it matters: Supports considering obliterative surgery in select older women, but evidence is from a narrative review of heterogeneous observational studies with low to very low certainty, not a pooled meta-analysis.
Urology clinical trials · Urology podcasts · Urology videos · Meetings · Daily edition archive
Loading today's edition…